MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Humana Accounts Receivables 2011-2025 | HUM
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Humana
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.7 B | 2.04 B | 1.67 B | 1.81 B | 1.14 B | 1.06 B | 1.02 B | 854 M | 1.28 B | 1.16 B | 1.17 B | 950 M | 733 M | 1.03 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.7 B | 733 M | 1.33 B |
Quarterly Accounts Receivables Humana
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.68 B | 4.5 B | 4.46 B | 2.14 B | 4.09 B | 3.92 B | 1.82 B | 1.43 B | 3.11 B | 1.67 B | 1.61 B | - | 3.17 B | 1.81 B | 1.88 B | 2.44 B | 2.2 B | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 1.02 B | 1.02 B | 1.02 B | 1.02 B | 854 M | 854 M | 854 M | 854 M | 1.28 B | 1.28 B | 1.28 B | 1.28 B | 1.16 B | 1.16 B | 1.16 B | 1.16 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 950 M | 950 M | 950 M | 950 M | 733 M | 733 M | 733 M | 733 M | 1.03 B | 1.03 B | 1.03 B | 1.03 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.5 B | 733 M | 1.5 B |
Accounts Receivables of other stocks in the Health care industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cigna Corporation
CI
|
24.2 B | $ 276.37 | 0.62 % | $ 75.7 B |  USA |
 |
CVS Health Corporation
CVS
|
36.5 B | $ 79.55 | 0.15 % | $ 100 B | USA |
 |
Molina Healthcare
MOH
|
3.3 B | $ 166.33 | -1.28 % | $ 9.55 B | USA |
 |
UnitedHealth Group Inc.
UNH
|
22.4 B | $ 340.29 | -0.45 % | $ 313 B | USA |
 |
NovoCure Limited
NVCR
|
74.2 M | $ 13.02 | -2.29 % | $ 1.4 B |  Jersey |